Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 2
2016 1
2017 6
2018 3
2019 4
2020 6
2021 7
2022 9
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Intraoperative High Positive End-Expiratory Pressure (PEEP) With Recruitment Maneuvers vs Low PEEP on Postoperative Pulmonary Complications in Obese Patients: A Randomized Clinical Trial.
Writing Committee for the PROBESE Collaborative Group of the PROtective VEntilation Network (PROVEnet) for the Clinical Trial Network of the European Society of Anaesthesiology; Bluth T, Serpa Neto A, Schultz MJ, Pelosi P, Gama de Abreu M; PROBESE Collaborative Group; Bluth T, Bobek I, Canet JC, Cinnella G, de Baerdemaeker L, Gama de Abreu M, Gregoretti C, Hedenstierna G, Hemmes SNT, Hiesmayr M, Hollmann MW, Jaber S, Laffey J, Licker MJ, Markstaller K, Matot I, Mills GH, Mulier JP, Pelosi P, Putensen C, Rossaint R, Schmitt J, Schultz MJ, Senturk M, Serpa Neto A, Severgnini P, Sprung J, Vidal Melo MF, Wrigge H. Writing Committee for the PROBESE Collaborative Group of the PROtective VEntilation Network (PROVEnet) for the Clinical Trial Network of the European Society of Anaesthesiology, et al. JAMA. 2019 Jun 18;321(23):2292-2305. doi: 10.1001/jama.2019.7505. JAMA. 2019. PMID: 31157366 Free PMC article. Clinical Trial.
Intraoperative positive end-expiratory pressure and postoperative pulmonary complications: a patient-level meta-analysis of three randomised clinical trials.
Campos NS, Bluth T, Hemmes SNT, Librero J, Pozo N, Ferrando C, Ball L, Mazzinari G, Pelosi P, Gama de Abreu M, Schultz MJ, Serpa Neto A; REPEAT; investigators for the PROVHILO study; iPROVE study; PROBESE study investigators; PROVE Network. Campos NS, et al. Br J Anaesth. 2022 Jun;128(6):1040-1051. doi: 10.1016/j.bja.2022.02.039. Epub 2022 Apr 15. Br J Anaesth. 2022. PMID: 35431038 Free article.
Breast Cancer Phenotypes in Africa: A Scoping Review and Meta-Analysis.
Onyia AF, Nana TA, Adewale EA, Adebesin AO, Adegboye BE, Paimo OK, De Campos OC, Bisi-Adeniyi TI, Rotimi OA, Oyelade JO, Rotimi SO. Onyia AF, et al. Among authors: adebesin ao. JCO Glob Oncol. 2023 Sep;9:e2300135. doi: 10.1200/GO.23.00135. JCO Glob Oncol. 2023. PMID: 38085060 Review.
StereoPHIP: Stereoselective Parahydrogen-Induced Polarization.
Huynh MT, Buchanan E, Chirayil S, Adebesin AM, Kovacs Z. Huynh MT, et al. Among authors: adebesin am. Angew Chem Int Ed Engl. 2023 Nov 13;62(46):e202311669. doi: 10.1002/anie.202311669. Epub 2023 Sep 26. Angew Chem Int Ed Engl. 2023. PMID: 37714818
20-Hydroxyeicosatetraenoic acid (20-HETE): Bioactions, receptors, vascular function, cardiometabolic disease and beyond.
Pascale JV, Wolf A, Kadish Y, Diegisser D, Kulaprathazhe MM, Yemane D, Ali S, Kim N, Baruch DE, Yahaya MAF, Dirice E, Adebesin AM, Falck JR, Schwartzman ML, Garcia V. Pascale JV, et al. Among authors: adebesin am. Adv Pharmacol. 2023;97:229-255. doi: 10.1016/bs.apha.2023.01.002. Epub 2023 Feb 24. Adv Pharmacol. 2023. PMID: 37236760 Free PMC article.
Cardioprotective Action of a Novel Synthetic 19,20-EDP Analog Is Sirt Dependent.
Kranrod JW, Darwesh AM, Bassiouni W, Huang A, Fang L, Korodimas JV, Adebesin AM, Munnuri S, Falck JR, Seubert JM. Kranrod JW, et al. Among authors: adebesin am. J Cardiovasc Pharmacol. 2024 Jan 1;83(1):105-115. doi: 10.1097/FJC.0000000000001495. J Cardiovasc Pharmacol. 2024. PMID: 38180457
Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment.
Akinnusi PA, Olubode SO, Adebesin AO, Nana TA, Shodehinde SA. Akinnusi PA, et al. Among authors: adebesin ao. Cancer Inform. 2022 Oct 4;21:11769351221127862. doi: 10.1177/11769351221127862. eCollection 2022. Cancer Inform. 2022. PMID: 36213305 Free PMC article.
44 results